Regulator
The FDA cleared new Ion software, including AI and imaging features, which Intuitive planned to release through a limited launch.
A regulator's decision · Company-reported · Sets Ion's stage
What the source says
“announced today that it received FDA clearance for new software advancements for its Ion endoluminal robot.”
What it means
Ion, from Intuitive, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. This event is one of the milestones that placed it there. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: The maker hasn't said whether people help it remotely.
More on Ion
- Intuitive placed 55 Ion systems in the second quarter of 2026, up from 54 a year earlier.
- Intuitive said more than 900 Ion systems were in hospitals across 10 countries.
- China's medical device regulator approved Ion for sale in China.
- Intuitive started a Class 2 recall of an Ion catheter because a ring at its tip could come off during a procedure.
- Intuitive said it would roll Ion out slowly in the US, with the first shipments to customers in the second quarter of 2019.
- The FDA cleared Ion for taking biopsies from the outer parts of the lung.